Skip to Content
MilliporeSigma
All Photos(1)

Documents

PHR2077

Supelco

Risedronate Related Compound C

Pharmaceutical Secondary Standard; Certified Reference Material

Synonym(s):

2-(3-Pyridinyl)ethylidene]bis(phosphonic acid), 2-(Pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid)

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C7H11NO6P2
CAS Number:
75755-10-1
Molecular Weight:
267.11
Beilstein/REAXYS Number:
9562253
MDL number:
MFCD26142887
UNSPSC Code:
41116107
NACRES:
NA.24

grade

certified reference material
pharmaceutical secondary standard

Quality Level

300

agency

traceable to Ph. Eur. Y0001540
traceable to USP 1604643

API family

risedronate

CofA

current certificate can be downloaded

packaging

pkg of 50 mg

application(s)

pharmaceutical

format

neat

storage temp.

2-30°C

SMILES string

OP(O)(C(CC1=CN=CC=C1)P(O)(O)=O)=O

InChI

1S/C7H11NO6P2/c9-15(10,11)7(16(12,13)14)4-6-2-1-3-8-5-6/h1-3,5,7H,4H2,(H2,9,10,11)(H2,12,13,14)

InChI key

KZMOFWIRXNQJET-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Risedronate Related Compound C is an impurity of risedronate, belonging to the group of pyridinyl bisphosphonates, and is effectively used in the treatment of Paget′s disease of bone. It is also used for the treatment of skeletal disorders since it inhibits osteoclast-mediated bone resorption and modulates bone metabolism.

Application

Risedronate may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using reversed-phase ion-pair high-performance liquid chromatographic method.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Analysis Note

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Footnote

To see an example of a Certificate of Analysis for this material enter LRAB8927 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

related product

Product No.
Description
Pricing

1604621

Risedronate Related Compound A, United States Pharmacopeia (USP) Reference Standard

1604632

Risedronate Related Compound B, United States Pharmacopeia (USP) Reference Standard

1604643

Risedronate Related Compound C, United States Pharmacopeia (USP) Reference Standard

1604610

Risedronate sodium, United States Pharmacopeia (USP) Reference Standard

Y0001558

Risedronate impurity A, European Pharmacopoeia (EP) Reference Standard

Y0001540

Risedronate impurity E, European Pharmacopoeia (EP) Reference Standard

Y0001541

Risedronate sodium 2.5-hydrate, European Pharmacopoeia (EP) Reference Standard

PHR1888

Risedronate Sodium, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2079

Risedronate Impurity D, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2078

Risedronate Impurity C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2075

Risedronate Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

pictograms

Health hazard
GHS08

signalword

Warning

hcodes

H361

Hazard Classifications

Repr. 2

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
LRAB8927

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations
Kyriakides D and Panderi I
Analytica Chimica Acta, 584(1), 153-159 (2007)
Stability indicating ion?pair HPLC method for the determination of risedronate in a commercial formulation
Aluoch A, et al.
Journal of Liquid Chromatography and Related Technologies, 27(17), 2799-2813 (2004)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service